Although it may be difficult to demonstrate improved patient outcomes, quality improvement efforts using team-based strategies and electronic medical record integration can improve performance on headache quality measures.
Adolescents with vs without painful temporomandibular disorder may have a greater risk for migraine and a greater frequency of headaches.
Remote delivery of psychological therapies to children and adolescents may have limited efficacy on headache, but no effect on other chronic pain conditions.
Parental attitudes, particularly maternal ones, may increase symptoms of depression and anxiety in children with episodic or chronic migraine or tension-type headache.
Children and adolescents undergoing infusion therapy for migraine were found to have higher levels of functional disability and a lower quality of life compared with patients not receiving infusion therapy.
There may be an association between childhood pain and additional missed school days and higher rates of chronic absenteeism.
The demographic characteristics and migraine diagnosis of pediatric patients with headache were found to be associated with the use of evidence-based medicine and prescriptions for opioids and barbiturates as first-line treatment.
An estimated 25% of children and adolescents report having pain that persists for more than 3 months, with severe and disabling pain affecting 8% of this population.
From 2013 to 2017, the rate of receiving a take-home opioid prescription remained stable after pediatric outpatient surgery as did the dose prescribed, but the maximum take-home dose declined.
Researchers reported full results of the 5-year GAS trial, the first randomized controlled trial to assess the effects of general anesthesia in infancy on neurodevelopmental outcomes.
